Colorectal surgeon Dr. Julio Garcia-Aguilar says there are a growing number of ways to treat colon and rectal cancer including advances in targeted therapy, surgery, and immunotherapy that can also ...

At 26, most people are juggling rent, careers, and group chats, not life-or-death medical decisions. So when a young woman ...

Two years ago, Emma Dimery was told her stage 4 colon cancer was incurable. Today, she is healthy and cancer-free — and she says a last-resort clinical trial saved her life. Dimery, who lives in ...

The surgical outcomes of colon cancer vary with its anatomical location. Neoadjuvant chemotherapy can aid in improving the postsurgical outcomes of both right and left colon cancer, decreasing the ...

Most people with colon cancer begin treatment by having surgery to remove their cancer. If colon cancer has spread beyond your colon, you might have chemotherapy first. This can help treat cancer ...

This article is brought to you by Ochsner Health. While overall rates of colorectal cancer have been declining in the United States, the numbers have been steadily increasing among younger patients.

CX-2051 demonstrated a 28% overall response rate in advanced colorectal cancer, with a 43% response at the highest dose of 10 mg/kg. The disease control rate was 94%, and median progression-free ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...

A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to late-stage trial data published Friday in The New England Journal of Medicine ...

Experts discuss additional factors considered when determining the most effective sequence of therapies for metastatic colorectal cancer, including fruquintinib, regorafenib, and trifluridine + ...